Literature DB >> 9670837

Molecular evidence of bone marrow involvement in advanced case ot Tgammadelta lymphoma with secondary myelofibrosis.

G Weirich1, M Sandherr, C Fellbaum, T Richter, L Schmidt, T Kinjerski, H Dietzfelbinger, J Rastetter, H Höfler.   

Abstract

We describe the case of a middle-aged man with long indolent course of generalized Tgammadelta lymphoma. The onset of secondary myelofibrosis made cytological monitoring of the bone marrow infiltrates impossible. As during progression of the disease splenectomy revealed typical histological features of a high-grade hepatosplenic Tgammadelta lymphoma, the low-grade bone infiltrate was considered a secondary lymphoma. The use of the polymerase chain reaction helped to detect a constant and identical monoclonal rearrangement pattern of the T-cell receptor gamma-chain gene in both bone marrow and splenic T-cell infiltrates. The notion of a secondary spread of malignant T-cells to the bone marrow was thereby confirmed despite striking cytological differences between bone marrow and splenic infiltrates. This is the first report of a diagnostic DNA-based molecular approach using fixed decalcified bone marrow. This method may provide a major tool when dealing with myelofibrosis, which normally hampers sampling of cytological specimens.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9670837     DOI: 10.1016/s0046-8177(98)90289-1

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  2 in total

Review 1.  Ancillary techniques in bone marrow pathology: molecular diagnostics on bone marrow trephine biopsies.

Authors:  Falko Fend; Oliver Bock; Markus Kremer; Katja Specht; Leticia Quintanilla-Martinez
Journal:  Virchows Arch       Date:  2005-10-18       Impact factor: 4.064

2.  Myelofibrosis-associated lymphoproliferative disease: retrospective study of 16 cases and literature review.

Authors:  A Etienne; B Gruson; D Chatelain; R Garidi; B Royer; H Sevestre; J P Marolleau; G Damaj
Journal:  Adv Hematol       Date:  2009-11-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.